DISPOSITION OF THE PSYCHOTROPIC-DRUGS BUSPIRONE, MJ-13805 AND PIRIBEDIL, AND OF THEIR COMMON ACTIVE METABOLITE 1-(2-PYRIMIDINYL)-PIPERAZINE IN THE RAT

被引:36
作者
CACCIA, S
FONG, MH
GUISO, G
机构
关键词
D O I
10.3109/00498258509045035
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:835 / 844
页数:10
相关论文
共 20 条
[1]   NONCOMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION [J].
BENET, LZ ;
GALEAZZI, RL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) :1071-1074
[2]   IDENTIFICATION AND QUANTITATION OF 1-(2-PYRIMIDINYL)PIPERAZINE, AN ACTIVE METABOLITE OF THE ANXIOLYTIC AGENT BUSPIRONE, IN RAT PLASMA AND BRAIN [J].
CACCIA, S ;
GARATTINI, S ;
MANCINELLI, A ;
MUGLIA, M .
JOURNAL OF CHROMATOGRAPHY, 1982, 252 (DEC) :310-314
[3]   PLASMA-CONCENTRATIONS OF TRAZODONE AND 1-(3-CHLOROPHENYL) PIPERAZINE IN MAN AFTER A SINGLE ORAL DOSE OF TRAZODONE [J].
CACCIA, S ;
FONG, MH ;
GARATTINI, S ;
ZANINI, MG .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (09) :605-606
[4]   DISPOSITION AND METABOLISM OF BUSPIRONE AND ITS METABOLITE 1-(2-PYRIMIDINYL)-PIPERAZINE IN THE RAT [J].
CACCIA, S ;
MUGLIA, M ;
MANCINELLI, A ;
GARATTINI, S .
XENOBIOTICA, 1983, 13 (03) :147-153
[5]   IDENTIFICATION AND QUANTITATION OF 1-ARYLPIPERAZINES, METABOLITES RESULTING FROM SIDE-CHAIN CLEAVAGE OF (4-SUBSTITUTED ARYL-1-PIPERAZINYL)ALKYL HETEROCYCLIC-DERIVATIVES IN RAT PLASMA AND BRAIN [J].
CACCIA, S ;
NOTARNICOLA, A ;
FONG, MH ;
BENFENATI, E .
JOURNAL OF CHROMATOGRAPHY, 1984, 283 (JAN) :211-221
[6]   ET495 AND BRAIN CATECHOLAMINE MECHANISMS - EVIDENCE FOR STIMULATION OF DOPAMINE RECEPTORS [J].
CORRODI, H ;
UNGERSTEDT, U ;
FUXE, K ;
HAMBERGER, B ;
FARNEBO, LO .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1972, 20 (02) :195-+
[7]   LEVELS OF PIRIBEDIL AND ITS ACTIVE METABOLITE (S-584) IN RAT STRIATUM [J].
FANELLI, R ;
FRIGERIO, A ;
GARATTINI, S .
XENOBIOTICA, 1975, 5 (10) :595-600
[8]   1-M-CHLOROPHENYLPIPERAZINE IS AN ACTIVE METABOLITE COMMON TO THE PSYCHOTROPIC-DRUGS TRAZODONE, ETOPERIDONE AND MEPIPRAZOLE [J].
FONG, MH ;
GARATTINI, S ;
CACCIA, S .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (10) :674-675
[9]  
GAMMANS RE, 1983, FED PROC, V42, P377
[10]  
GARATTINI S, 1975, 1ST P INT S PIR MON, P240